Dashboard
Manage Tickers

LQDALiquidia Technologies Inc

Nasdaq www.liquidia.com


$ 12.38 $ -0.18 (-1.43 %)    

Thursday, 25-Apr-2024 15:59:57 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 430.17 $ -2.06 (-0.48 %)
DIA $ 380.88 $ -3.52 (-0.92 %)
SPY $ 507.81 $ -1.92 (-0.38 %)
TLT $ 87.78 $ -0.62 (-0.7 %)
GLD $ 215.92 $ 1.28 (0.6 %)
$ 12.37
$ 12.33
$ 0.00 x 0
$ 12.38 x 300
$ 11.82 - $ 12.46
$ 5.71 - $ 16.99
1,197,229
na
467M
$ 0.64
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-06-2020 09-30-2020 10-Q
2 08-10-2020 06-30-2020 10-Q
3 05-11-2020 03-31-2020 10-Q
4 03-16-2020 12-31-2019 10-K
5 11-13-2019 09-30-2019 10-Q
6 08-14-2019 06-30-2019 10-Q
7 05-02-2019 03-31-2019 10-Q
8 02-26-2019 12-31-2018 10-K
9 10-31-2018 09-30-2018 10-Q
10 08-14-2018 06-30-2018 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

jim-cramer-youre-dice-rolling-with-this-biopharma-stock-but-vista-energy-is-a-good-situation
Jim Cramer: You're 'Dice Rolling' With Thi...
04/25/2024 12:18:21

"Mad Money Lightning Round," Jim Cramer recommended buying Cloudflare. "I would buy it slowly because we've got...

needham-reiterates-buy-on-liquidia-maintains-28-price-target
Needham Reiterates Buy on Liquidia, Mainta...
04/10/2024 11:02:07

Needham analyst Serge Belanger reiterates Liquidia (NASDAQ:LQDA) with a Buy and maintains $28 price target.

the-analyst-landscape-5-takes-on-liquidia
The Analyst Landscape: 5 Takes On Liquidia
04/01/2024 18:00:45

needham-reiterates-buy-on-liquidia-maintains-28-price-target
Needham Reiterates Buy on Liquidia, Mainta...
04/01/2024 14:27:22

Needham analyst Serge Belanger reiterates Liquidia (NASDAQ:LQDA) with a Buy and maintains $28 price target.

Core News & Articles
Liquidia Says Judge Andrews Has Set Aside ...
04/01/2024 10:09:19

why-luxurban-hotels-shares-are-trading-lower-by-around-27-here-are-other-stocks-moving-in-wednesdays-mid-day-session
Why LuxUrban Hotels Shares Are Trading Low...
03/27/2024 17:06:58

Shares of LuxUrban Hotels Inc. (NASDAQ: LUXH) fell sharply during Wednesday’s session after the company issued preliminary fo...

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
03/18/2024 17:35:23

hc-wainwright--co-maintains-buy-on-liquidia-raises-price-target-to-32
HC Wainwright & Co. Maintains Buy on Liqui...
03/14/2024 15:45:31

HC Wainwright & Co. analyst Andrew Fein maintains Liquidia (NASDAQ:LQDA) with a Buy and raises the price target from $16...

build-a-bear-workshop-reports-upbeat-earnings-joins-vaalco-energy-dicks-sporting-goods-and-other-big-stocks-moving-higher-on-thursday
Build-A-Bear Workshop Reports Upbeat Earni...
03/14/2024 14:38:19

U.S. stocks were lower, with the Dow Jones index falling more than 100 points on Thursday.

unveiling-6-analyst-insights-on-liquidia
Unveiling 6 Analyst Insights On Liquidia
03/13/2024 21:00:42

needham-maintains-buy-on-liquidia-maintains-28-price-target
Needham Maintains Buy on Liquidia, Maintai...
03/13/2024 20:10:05

Needham analyst Serge Belanger maintains Liquidia (NASDAQ:LQDA) with a Buy and maintains $28 price target.

earnings-scheduled-for-march-13-2024
Earnings Scheduled For March 13, 2024
03/13/2024 10:15:56

Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share...

recap-ishares--corp-bond-ucits-etf-q4-earnings
Recap: iShares $ Corp Bond UCITS ETF Q4 Ea...
03/13/2024 10:15:05

liquidia-fy-gaap-eps-121-misses-102-estimate-sales-1749m-miss-1769m-estimate
Liquidia FY GAAP EPS $(1.21) Misses $(1.02...
03/13/2024 10:06:33

Liquidia (NASDAQ:LQDA) reported quarterly losses of $(1.21) per share which missed the analyst consensus estimate of $(1.02) by...

liquidia-earnings-preview
Liquidia Earnings Preview
03/12/2024 15:01:51

Core News & Articles
United Therapeutics Filed Motion In U.S. D...
02/27/2024 11:18:25

Liquidia’s investigational product is currently tentatively approved by the FDA for the treatment of pulmonary arterial hyperte...

needham-reiterates-buy-on-liquidia-maintains-28-price-target
Needham Reiterates Buy on Liquidia, Mainta...
02/21/2024 18:18:14

Needham analyst Serge Belanger reiterates Liquidia (NASDAQ:LQDA) with a Buy and maintains $28 price target.

united-therapeutics-challenges-fda-over-liquidias-drug-approval-process-clocks-strong-q4-earnings
United Therapeutics' Challenges FDA Over L...
02/21/2024 18:17:03

Legal battle unfolds as United Therapeutics challenges FDA's handling of Liquidia's drug approval process. Explore the ...

Core News & Articles
United Therapeutics Has Commenced Litigati...
02/21/2024 10:59:20

this-united-therapeutics-analyst-is-no-longer-bearish-expects-mid-decade-4b-revenue-run-rate
This United Therapeutics Analyst Is No Lon...
02/12/2024 16:00:04

United Therapeutics Corporation (NASDAQ: UTHR) is in a patent dispute with Liquidia Corp (NASDAQ:

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION